世界のハースル細胞がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hurthle Cell Carcinoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4335
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ハースル細胞がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一般外科、甲状腺全摘、ロボット支援手術、放射性ヨウ素（RAI）、その他）、用途別市場規模（病院、外科医院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ハースル細胞がん治療の市場動向
・企業の競争状況、市場シェア
・ハースル細胞がん治療の種類別市場規模と予測2016-2027（一般外科、甲状腺全摘、ロボット支援手術、放射性ヨウ素（RAI）、その他）
・ハースル細胞がん治療の用途別市場規模と予測2016-2027（病院、外科医院、クリニック、その他）
・ハースル細胞がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・ハースル細胞がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ハースル細胞がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ハースル細胞がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ハースル細胞がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Smith & Nephew、Pfizer、EISAI、Sanofi-Aventis、Sun Pharmaceuticals、Cadila Healthcare）
・結論

Market Analysis and Insights: Global Hurthle Cell Carcinoma Treatment Market
The global Hurthle Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hurthle Cell Carcinoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hurthle Cell Carcinoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hurthle Cell Carcinoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hurthle Cell Carcinoma Treatment market.

Global Hurthle Cell Carcinoma Treatment Scope and Market Size
Hurthle Cell Carcinoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hurthle Cell Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
General Surgery
Total Thyroidectomy
Robotic Surgery
Radioactive Iodine (RAI)
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Smith & Nephew
Pfizer
EISAI
Sanofi-Aventis
Sun Pharmaceuticals
Cadila Healthcare

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hurthle Cell Carcinoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 General Surgery
1.2.3 Total Thyroidectomy
1.2.4 Robotic Surgery
1.2.5 Radioactive Iodine (RAI)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hurthle Cell Carcinoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hurthle Cell Carcinoma Treatment Market Perspective (2016-2027)
2.2 Hurthle Cell Carcinoma Treatment Growth Trends by Regions
2.2.1 Hurthle Cell Carcinoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hurthle Cell Carcinoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hurthle Cell Carcinoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hurthle Cell Carcinoma Treatment Industry Dynamic
2.3.1 Hurthle Cell Carcinoma Treatment Market Trends
2.3.2 Hurthle Cell Carcinoma Treatment Market Drivers
2.3.3 Hurthle Cell Carcinoma Treatment Market Challenges
2.3.4 Hurthle Cell Carcinoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hurthle Cell Carcinoma Treatment Players by Revenue
3.1.1 Global Top Hurthle Cell Carcinoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hurthle Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hurthle Cell Carcinoma Treatment Revenue
3.4 Global Hurthle Cell Carcinoma Treatment Market Concentration Ratio
3.4.1 Global Hurthle Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hurthle Cell Carcinoma Treatment Revenue in 2020
3.5 Hurthle Cell Carcinoma Treatment Key Players Head office and Area Served
3.6 Key Players Hurthle Cell Carcinoma Treatment Product Solution and Service
3.7 Date of Enter into Hurthle Cell Carcinoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hurthle Cell Carcinoma Treatment Breakdown Data by Type
4.1 Global Hurthle Cell Carcinoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Type (2022-2027)

5 Hurthle Cell Carcinoma Treatment Breakdown Data by Application
5.1 Global Hurthle Cell Carcinoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hurthle Cell Carcinoma Treatment Market Size (2016-2027)
6.2 North America Hurthle Cell Carcinoma Treatment Market Size by Type
6.2.1 North America Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2027)
6.3 North America Hurthle Cell Carcinoma Treatment Market Size by Application
6.3.1 North America Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2027)
6.4 North America Hurthle Cell Carcinoma Treatment Market Size by Country
6.4.1 North America Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hurthle Cell Carcinoma Treatment Market Size (2016-2027)
7.2 Europe Hurthle Cell Carcinoma Treatment Market Size by Type
7.2.1 Europe Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2027)
7.3 Europe Hurthle Cell Carcinoma Treatment Market Size by Application
7.3.1 Europe Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2027)
7.4 Europe Hurthle Cell Carcinoma Treatment Market Size by Country
7.4.1 Europe Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Type
8.2.1 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Application
8.3.1 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Region
8.4.1 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hurthle Cell Carcinoma Treatment Market Size (2016-2027)
9.2 Latin America Hurthle Cell Carcinoma Treatment Market Size by Type
9.2.1 Latin America Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Hurthle Cell Carcinoma Treatment Market Size by Application
9.3.1 Latin America Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Hurthle Cell Carcinoma Treatment Market Size by Country
9.4.1 Latin America Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Type
10.2.1 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Application
10.3.1 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Country
10.4.1 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Smith & Nephew
11.1.1 Smith & Nephew Company Details
11.1.2 Smith & Nephew Business Overview
11.1.3 Smith & Nephew Hurthle Cell Carcinoma Treatment Introduction
11.1.4 Smith & Nephew Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021)
11.1.5 Smith & Nephew Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hurthle Cell Carcinoma Treatment Introduction
11.2.4 Pfizer Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 EISAI
11.3.1 EISAI Company Details
11.3.2 EISAI Business Overview
11.3.3 EISAI Hurthle Cell Carcinoma Treatment Introduction
11.3.4 EISAI Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021)
11.3.5 EISAI Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Hurthle Cell Carcinoma Treatment Introduction
11.4.4 Sanofi-Aventis Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Sun Pharmaceuticals
11.5.1 Sun Pharmaceuticals Company Details
11.5.2 Sun Pharmaceuticals Business Overview
11.5.3 Sun Pharmaceuticals Hurthle Cell Carcinoma Treatment Introduction
11.5.4 Sun Pharmaceuticals Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021)
11.5.5 Sun Pharmaceuticals Recent Development
11.6 Cadila Healthcare
11.6.1 Cadila Healthcare Company Details
11.6.2 Cadila Healthcare Business Overview
11.6.3 Cadila Healthcare Hurthle Cell Carcinoma Treatment Introduction
11.6.4 Cadila Healthcare Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021)
11.6.5 Cadila Healthcare Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hurthle Cell Carcinoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of General Surgery
Table 3. Key Players of Total Thyroidectomy
Table 4. Key Players of Robotic Surgery
Table 5. Key Players of Radioactive Iodine (RAI)
Table 6. Key Players of Others
Table 7. Global Hurthle Cell Carcinoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hurthle Cell Carcinoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hurthle Cell Carcinoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hurthle Cell Carcinoma Treatment Market Share by Regions (2016-2021)
Table 11. Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hurthle Cell Carcinoma Treatment Market Share by Regions (2022-2027)
Table 13. Hurthle Cell Carcinoma Treatment Market Trends
Table 14. Hurthle Cell Carcinoma Treatment Market Drivers
Table 15. Hurthle Cell Carcinoma Treatment Market Challenges
Table 16. Hurthle Cell Carcinoma Treatment Market Restraints
Table 17. Global Hurthle Cell Carcinoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hurthle Cell Carcinoma Treatment Market Share by Players (2016-2021)
Table 19. Global Top Hurthle Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hurthle Cell Carcinoma Treatment as of 2020)
Table 20. Ranking of Global Top Hurthle Cell Carcinoma Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hurthle Cell Carcinoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hurthle Cell Carcinoma Treatment Product Solution and Service
Table 24. Date of Enter into Hurthle Cell Carcinoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hurthle Cell Carcinoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Smith & Nephew Company Details
Table 65. Smith & Nephew Business Overview
Table 66. Smith & Nephew Hurthle Cell Carcinoma Treatment Product
Table 67. Smith & Nephew Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 68. Smith & Nephew Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Hurthle Cell Carcinoma Treatment Product
Table 72. Pfizer Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. EISAI Company Details
Table 75. EISAI Business Overview
Table 76. EISAI Hurthle Cell Carcinoma Treatment Product
Table 77. EISAI Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 78. EISAI Recent Development
Table 79. Sanofi-Aventis Company Details
Table 80. Sanofi-Aventis Business Overview
Table 81. Sanofi-Aventis Hurthle Cell Carcinoma Treatment Product
Table 82. Sanofi-Aventis Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 83. Sanofi-Aventis Recent Development
Table 84. Sun Pharmaceuticals Company Details
Table 85. Sun Pharmaceuticals Business Overview
Table 86. Sun Pharmaceuticals Hurthle Cell Carcinoma Treatment Product
Table 87. Sun Pharmaceuticals Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 88. Sun Pharmaceuticals Recent Development
Table 89. Cadila Healthcare Company Details
Table 90. Cadila Healthcare Business Overview
Table 91. Cadila Healthcare Hurthle Cell Carcinoma Treatment Product
Table 92. Cadila Healthcare Revenue in Hurthle Cell Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 93. Cadila Healthcare Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hurthle Cell Carcinoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. General Surgery Features
Figure 3. Total Thyroidectomy Features
Figure 4. Robotic Surgery Features
Figure 5. Radioactive Iodine (RAI) Features
Figure 6. Others Features
Figure 7. Global Hurthle Cell Carcinoma Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Hurthle Cell Carcinoma Treatment Report Years Considered
Figure 13. Global Hurthle Cell Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Hurthle Cell Carcinoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hurthle Cell Carcinoma Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Hurthle Cell Carcinoma Treatment Market Share by Regions (2022-2027)
Figure 17. Global Hurthle Cell Carcinoma Treatment Market Share by Players in 2020
Figure 18. Global Top Hurthle Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hurthle Cell Carcinoma Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Hurthle Cell Carcinoma Treatment Revenue in 2020
Figure 20. Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Hurthle Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 24. North America Hurthle Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 25. North America Hurthle Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 26. United States Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hurthle Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 30. Europe Hurthle Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 31. Europe Hurthle Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 32. Germany Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Hurthle Cell Carcinoma Treatment Market Share by Region (2016-2027)
Figure 42. China Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hurthle Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Hurthle Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Hurthle Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Hurthle Cell Carcinoma Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Smith & Nephew Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2016-2021)
Figure 63. EISAI Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2016-2021)
Figure 64. Sanofi-Aventis Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2016-2021)
Figure 65. Sun Pharmaceuticals Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2016-2021)
Figure 66. Cadila Healthcare Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の皮膚扁平上皮がん治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Squamous Cell Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4084 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚扁平上皮がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、非外科的治療）、用途別市場規模（病院、がん研究所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の胸腺がん治療市場規模・現状・予測（2021年-2027年）

Global Thymic Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6040 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、胸腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベリノスタット、パシレオチドER、ミルシクリブ、TLC-388、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北...

世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年）

Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5819 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓癌＆腎細胞癌（RCC）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アフィニトール（エベロリムス）、アバスチン（ベバシズマブ）、カボメティ（カボザンチニブ）、インリタ（アキシチニブ）、ネク...

世界の内分泌癌治療市場規模・現状・予測（2021年-2027年）

Global Neuroendocrine Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4566 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、内分泌癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ソマトスタチン類似体、標的療法、化学療法）、用途別市場規模（病院、クリニック、オンコロジーセンター、外来手術センター、その他）、主要地域別市...

世界の腎細胞がん臨床試験パイプライン市場規模・現状・予測（2021年-2027年）

Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4808 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、腎細胞がん臨床試験パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法）、用途別市場規模（病院、研究所、商業、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年）

Global T-cell Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、T細胞急性リンパ芽球性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous B-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4075 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚B細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規...

世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年）

Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3894 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、B細胞非ホジキンリンパ腫（NHL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米...

世界の線維形成性小円形細胞腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Desmoplastic Small Round Cell Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4116 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、線維形成性小円形細胞腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、外科手術、化学療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の脱毛症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Alopecia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4901 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、脱毛症幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（円形脱毛症、全頭脱毛症、全身性脱毛症）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の皮膚扁平上皮がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Squamous Cell Carcinoma Treatment Market The global Cutaneous Squamous Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
世界の内分泌癌治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Neuroendocrine Carcinoma Treatment Market The global Neuroendocrine Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年） Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is the tenth most common cause of cancer for women. Market Analysis and Insights: Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market The glo…
世界の胸腺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thymic Carcinoma Treatment Market The global Thymic Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
世界の腎細胞がん臨床試験パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Renal Cell Carcinoma Clinical Trial Pipeline Market The global Renal Cell Carcinoma Clinical Trial Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…